Nanjing, Jiangsu
China
Herpes zoster, gE-Fc fusion vaccine, subunit vaccine, immunogenicity, safety, non-inferiority trial
COVID-19, adenovirus type-5 vector-based COVID-19 vaccine, immunogenicity, safety, needle-free injector